CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Revenues | ||||
| Total revenues | $ 30,800,158 | $ 21,596,478 | $ 87,090,653 | $ 59,272,980 |
| Cost of revenues | 10,880,300 | 9,446,089 | 31,054,827 | 23,676,598 |
| Gross profit | 19,919,858 | 12,150,389 | 56,035,826 | 35,596,382 |
| Operating expenses | ||||
| Selling, general and administrative | 10,291,131 | 8,378,018 | 27,752,063 | 23,976,238 |
| Depreciation and amortization | 2,309,103 | 2,190,420 | 7,285,088 | 6,111,520 |
| Total operating expenses | 12,600,234 | 10,568,438 | 35,037,151 | 30,087,758 |
| Income from operations | 7,319,624 | 1,581,951 | 20,998,675 | 5,508,624 |
| Other income | ||||
| Interest income, net | 870,573 | 663,666 | 2,565,639 | 2,031,024 |
| Income before income tax provision | 8,190,197 | 2,245,617 | 23,564,314 | 7,539,648 |
| Income tax provision | 1,454,503 | 30,482 | 4,633,165 | 1,350,652 |
| Net income | $ 6,735,694 | $ 2,215,135 | $ 18,931,149 | $ 6,188,996 |
| Net income per share | ||||
| Basic | $ 0.12 | $ 0.04 | $ 0.34 | $ 0.11 |
| Diluted | $ 0.11 | $ 0.04 | $ 0.30 | $ 0.10 |
| Weighted average common shares | ||||
| Basic | 56,703,842 | 54,797,527 | 56,000,291 | 54,205,002 |
| Diluted | 62,719,220 | 61,770,520 | 62,368,383 | 58,955,421 |
| Plasma Industry [Member] | ||||
| Revenues | ||||
| Total revenues | $ 13,826,621 | $ 12,860,478 | $ 38,615,772 | $ 33,014,282 |
| Pharma Industry [Member] | ||||
| Revenues | ||||
| Total revenues | 16,620,579 | 7,920,604 | 46,949,164 | 24,293,163 |
| Other Revenue [Member] | ||||
| Revenues | ||||
| Total revenues | $ 352,958 | $ 815,396 | $ 1,525,717 | $ 1,965,535 |
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|